Citigroup (C)

NYSEFinancialsBanks - DiversifiedSnapshot 2026-10-15

$124.26+0.85%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge Citigroup’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+0.2%

+10% or more+5%0%−5%−10% or less

12.80 → 12.82 EPS · FY ending Dec 31, 2027 · 13 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 13 to 13; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

Three key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Revenue growth near 9% per year	A primary condition in Citigroup's published investment case. The stated target is >=9% YoY revenue growth.	Intact	YoY revenue growth falls below 7% next year	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 4 of last 4 quarters. RoTCE improved from 8.0% in 2025-Q4 to 13.0% in 2026-Q1 and was 11.5% in 2026-Q2, showing progress above the 10-11% target range. Management reiterated commitment to this target each quarter, and the trajectory is delivering. Delivery assessment Oct 15, 2026
Return on Tangible Common Equity (RoTCE) at or above 10%	A primary condition in Citigroup's published investment case. The stated target is >=10% RoTCE.	Intact	RoTCE falls below 10% in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 4 of last 4 quarters. RoTCE improved from 8.0% in 2025-Q4 to 13.0% in 2026-Q1 and was 11.5% in 2026-Q2, showing progress above the 10-11% target range. Management reiterated commitment to this target each quarter, and the trajectory is delivering. Delivery assessment Oct 15, 2026
Successful expansion of metal clearing and investment banking services	It is expanding services like metal clearing to grow.	Intact	Loss of key clearing memberships or decline in India banking rank	Qualitative condition This condition has no defined numerical measure. Context reviewed through Oct 15, 2026Last status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$12.82

$12.81 → $12.82 · observed estimates

FY2027 revenue$99.86B

$99.27B → $99.86B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$12.81	$99,272,635,070	11 / 17
2026-07-25	$12.75	$99,248,684,680	13 / 14
2026-07-26	$12.81	$99,318,603,360	11 / 17
2026-07-27	$12.81	$99,318,603,360	11 / 17
2026-07-28	$12.81	$99,318,603,360	11 / 17
2026-07-29	$12.81	$99,318,603,360	11 / 17
2026-07-30	$12.81	$99,318,603,360	11 / 17
2026-07-31	$12.76	$99,281,250,338	13 / 14
2026-08-01	$12.83	$99,391,577,600	11 / 17
2026-08-02	$12.83	$99,391,577,600	11 / 17
2026-08-03	$12.77	$99,366,250,338	13 / 14
2026-08-04	$12.83	$99,391,577,600	11 / 17
2026-08-05	$12.88	$99,514,974,480	11 / 17
2026-08-06	$12.88	$99,514,974,480	11 / 17
2026-08-07	$12.77	$99,366,250,338	13 / 14
2026-08-08	$12.77	$99,366,250,338	13 / 14
2026-08-09	$12.88	$99,514,974,480	11 / 17
2026-08-10	$12.88	$99,514,974,480	11 / 17
2026-08-11	$12.88	$99,514,974,480	11 / 17
2026-08-12	$12.77	$99,366,250,338	13 / 14
2026-08-13	$12.77	$99,366,250,338	13 / 14
2026-08-14	$12.77	$99,366,250,338	13 / 14
2026-08-15	$12.77	$99,366,250,338	13 / 14
2026-08-16	$12.77	$99,366,250,338	13 / 14
2026-08-17	$12.77	$99,366,250,338	13 / 14
2026-08-18	$12.77	$99,366,250,338	13 / 14
2026-08-19	$12.77	$99,366,250,338	13 / 14
2026-08-20	$12.77	$99,366,250,338	13 / 14
2026-08-21	$12.80	$99,514,266,786	13 / 14
2026-08-22	$12.80	$99,514,266,786	13 / 14
2026-08-23	$12.80	$99,514,266,786	13 / 14
2026-08-24	$12.80	$99,514,266,786	13 / 14
2026-08-25	$12.80	$99,514,266,786	13 / 14
2026-08-26	$12.80	$99,514,266,786	13 / 14
2026-08-27	$12.80	$99,514,266,786	13 / 14
2026-08-28	$12.80	$99,514,266,786	13 / 14
2026-08-29	$12.80	$99,514,266,786	13 / 14
2026-08-30	$12.80	$99,514,266,786	13 / 14
2026-08-31	$12.80	$99,514,266,786	13 / 14
2026-09-01	$12.80	$99,514,266,786	13 / 14
2026-09-02	$12.80	$99,514,266,786	13 / 14
2026-09-03	$12.80	$99,514,266,786	13 / 14
2026-09-04	$12.80	$99,514,266,786	13 / 14
2026-09-05	$12.80	$99,514,266,786	13 / 14
2026-09-06	$12.80	$99,514,266,786	13 / 14
2026-09-07	$12.80	$99,514,266,786	13 / 14
2026-09-08	$12.80	$99,514,266,786	13 / 14
2026-09-09	$12.80	$99,566,744,089	13 / 14
2026-09-10	$12.80	$99,557,580,217	13 / 14
2026-09-11	$12.80	$99,557,580,217	13 / 14
2026-09-12	$12.80	$99,557,580,217	13 / 14
2026-09-13	$12.80	$99,557,580,217	13 / 14
2026-09-14	$12.80	$99,557,580,217	13 / 14
2026-09-15	$12.80	$99,557,580,217	13 / 14
2026-09-16	$12.80	$99,557,580,217	13 / 14
2026-09-17	$12.80	$99,565,156,050	13 / 14
2026-09-18	$12.80	$99,565,156,050	13 / 14
2026-09-19	$12.80	$99,565,156,050	13 / 14
2026-09-20	$12.80	$99,565,156,050	13 / 14
2026-09-21	$12.80	$99,565,156,050	13 / 14
2026-09-22	$12.80	$99,565,156,050	13 / 14
2026-09-23	$12.80	$99,565,156,050	13 / 14
2026-09-24	$12.80	$99,565,156,050	13 / 13
2026-09-25	$12.80	$99,554,280,878	13 / 13
2026-09-26	$12.80	$99,549,914,484	13 / 13
2026-09-27	$12.80	$99,549,914,484	13 / 13
2026-09-28	$12.80	$99,549,914,484	13 / 13
2026-09-29	$12.80	$99,565,735,205	13 / 13
2026-09-30	$12.79	$99,536,457,427	13 / 13
2026-10-01	$12.79	$99,536,457,427	13 / 13
2026-10-02	$12.80	$99,571,816,844	13 / 13
2026-10-03	$12.78	$99,589,139,182	13 / 13
2026-10-04	$12.78	$99,589,139,182	13 / 13
2026-10-05	$12.77	$99,589,139,182	13 / 13
2026-10-06	$12.79	$99,630,603,904	13 / 13
2026-10-07	$12.79	$99,628,492,793	12 / 14
2026-10-08	$12.79	$99,628,492,793	13 / 14
2026-10-09	$12.81	$99,757,767,720	13 / 14
2026-10-10	$12.81	$99,757,767,720	14 / 15
2026-10-11	$12.81	$99,757,767,720	14 / 14
2026-10-12	$12.81	$99,757,767,720	14 / 14
2026-10-13	$12.81	$99,757,767,720	14 / 13
2026-10-14	$12.82	$99,816,373,501	14 / 13
2026-10-15	$12.82	$99,858,932,329	13 / 13

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	19	4
2026-06-01	18	5
2026-07-01	18	5
2026-08-01	17	5
2026-09-01	17	5
2026-10-01	18	5

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 18 Buy / Strong Buy · 5 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades7 maintains

Recent actions · Sep 16–Oct 15 · 7 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

UBSOct 14 · prior Aug 3

$142.00 → $148.00+4.2%

RBC CapitalOct 14

$135.00New observation · no comparable prior

Evercore ISIOct 14 · prior Oct 1

$140.00 → $135.00-3.6%

Loop Capital MarketsOct 13

$155.00New observation · no comparable prior

HSBCSep 28

$164.00New observation · no comparable prior

$0$90.20$180.40

1 raises · 1 cuts · 0 unchanged · 3 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Revenue growth near 9% per yearDirect metric needs a verified mapping
Return on Tangible Common Equity (RoTCE) at or above 10%Direct metric needs a verified mapping
Successful expansion of metal clearing and investment banking servicesQualitative condition

Next proof point

Next earnings date unavailable

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.0%Typical daily move · historical

Downside history

-16.1%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Citigroup outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

This investment is characterized as a stable compounder with a focus on returning capital to shareholders. The current thesis state is cautious, given the recent weak financial performance and medium confidence in the company's trajectory.

What's priced into Citigroup

The market seems to have priced in a neutral valuation, suggesting that Citigroup is considered cheap compared to its peers. There is a slight expectations gap, indicating that investors may be anticipating less favorable outcomes than what the company has delivered recently.

What the fundamentals likely do

Management is on track to meet its return on tangible common equity (RoTCE) target and has consistently returned capital to shareholders. However, the recent financial performance has been weak, which raises concerns about the company's ability to maintain momentum.

What Citigroup hinges on

The long-term thesis hinges on management's ability to execute on its transformation programs and maintain RoTCE targets. Additionally, external factors like interest rate changes and performance from sector peers will significantly influence Citigroup's trajectory.